Geode Capital Management’s Cogentix Medical, Inc. CGNT Stock Holding History

Geode Capital Management’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-181,971	Closed	-$700K	–	4169
2018 Q1	$700K	Hold	181,971	–	–	﹤0.01%	3282
2017 Q4	$573K	Hold	181,971	–	–	﹤0.01%	3306
2017 Q3	$465K	Hold	181,971	–	–	﹤0.01%	3389
2017 Q2	$316K	Sell	181,971 -5,141	-3%	-$8.82K	﹤0.01%	3520
2017 Q1	$336K	Buy	187,112 +5,141	+3%	+$10.2K	﹤0.01%	3468
2016 Q4	$365K	Buy	181,971 +95,810	+111%	+$196K	﹤0.01%	3389
2016 Q3	$156K	Buy	86,161 +31,070	+56%	+$40.2K	﹤0.01%	3675
2016 Q2	$52K	Hold	55,091	–	–	﹤0.01%	3920
2016 Q1	$60	Hold	55,091	–	–	﹤0.01%	3941
2015 Q4	$71K	Hold	55,091	–	–	﹤0.01%	3953
2015 Q3	$68K	Buy	+55,091	New	+$84.5K	﹤0.01%	3968

Geode Capital Management's CGNT Position: Q2 2018 in Review

Geode Capital Management sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 181,971 shares — an estimated $700K sold.

Geode Capital Management first reported a position in CGNT in Q3 2015 and held it in 11 quarters. The position peaked at $700K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Geode Capital Management reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Geode Capital Management sold 181,971 Cogentix Medical, Inc. shares in Q2 2018, an estimated $700K.
Geode Capital Management first reported a position in Cogentix Medical, Inc. in Q3 2015 and held it in 11 quarters.
Geode Capital Management's Cogentix Medical, Inc. position peaked at $700K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Geode Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.